Martin D. Madaus is Chairman, President and Chief Executive Officer of Millipore Corporation. Millipore (NYSE: MIL), headquartered in Billerica, MA, is a global Life Science Tools company with revenues of approximately $1.65 billion. The Company focuses on two business segments: biopharmaceutical manufacturing and life science research and analytical laboratories. The Bioprocess Division offers solutions that enable development and manufacturing of biologics. The Bioscience Division provides high performance products and application insights that improve laboratory productivity.

Dr. Madaus joined Millipore in January 2005 as President and Chief Executive Officer and became Chairman of the Board in March 2005.

Dr. Madaus came to Millipore from Roche Diagnostics Corporation where, as President and Chief Executive Officer (2000-2004), he was responsible for the North American Operations. Prior to that (1999), he was Vice President of Business Development for Roche Molecular Diagnostics. Dr. Madaus joined Roche in 1998 when he was general manager of Boehringer Mannheim Canada in Montreal, Quebec, through the acquisition of Boehringer Mannheim by Roche. From 1989 to 1998, Dr. Madaus worked at Boehringer Mannheim in senior management, sales and marketing, and product management roles both in Germany and in the United States.

Dr. Madaus is a director of Mettler-Toledo International Inc. and the Massachusetts High Technology Council. He is co-chair of the Massachusetts Climate Protection and Green Economy Advisory Committee, and he serves on the Life Sciences Collaborative Leadership Council of the Massachusetts Technology Collaborative.

Dr. Madaus is a native of Hamburg, Germany (naturalized American citizen), and holds a D.V.M. and Ph.D. in veterinary medicine. He is married and has three children.